Kidney neoplasms account for 2.2% of total neoplasms worldwide 1 . Renal cell carcinoma (RCC) accounts for 2% of global cancer incidence and mortality, making it the seventh most common neoplasm 1 . It has a male predominance, with a relative risk of 1.7 when compared to women, and with a higher incidence in developed countries 1 . Survival depends on the stage at the time of diagnosis; stage I, localized cancer has 93%, while stage IV has a 12% 5-year survival rate 1 . The mortality rate among all cancer deaths is 1.8%, and it remained the same in the last 35 years despite a doubling incidence, most likely due to improvements in diagnostics and treatment 1 . Today, most cases are diagnosed incidentally, using ultrasound (US), computed tomography (CT), or magnetic resonance imaging (MRI). RCC has several subtypes, but the most common are clear cell, papillary, and chromophobe carcinoma, which account for 75%, 10%, and 5% of